Search
  • subash srikantha

COVID-19 interstitial pneumonia: monitoring the clinical course in survivors

The varying extent of pulmonary fibrosis and lung function impairment among survivors of COVID-19, and the unknown course of such abnormalities, highlight the need for pulmonary clinicians to closely monitor disease course in survivors. Such follow-up will generate knowledge about the natural course of disease and facilitate enrolment in clinical trials assessing the treatment of abnormalities with immune modulating drugs and antifibrotic drugs

Source: Lancet 03 Aug 2020

6 views

Suite 203, 5, celebration drive Bellavista 2153

  • White Facebook Icon
  • White Twitter Icon
  • White Google+ Icon

Tel: 02-88834558

© 2023 by NRSD